New Filings & Updated Terms (Ending 6.14.19am)

NEW FILINGS

Company: Wanda Sports Group Company Limited
Symbol: WSG
Description: They are a global sports events, media and marketing platform with significant intellectual property rights, long-term relationships and broad execution capabilities through which we create value for stakeholders in all parts of the sports ecosystem, from rights owners, to brands and advertisers, and to fans and athletes.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Morgan Stanley, Deutsche Bank, Citigroup
Co-Manager(s): Haitong International, CICC, CLSA
Filed: 6-7-19
Listed Cash Raise: $500m

TERMS ADDED

Company: Morphic Holding, Inc.
Symbol: MORF
Description: They are a biopharmaceutical company applying our proprietary insights into integrins to discover and develop a pipeline of potentially first-in-class oral small-molecule integrin therapeutics.
Shares: 5 million
Price Range: $14.00-$16.00
Trade Date: Thursday, 6/27
Terms Added: 6-14-19

Company: Change Healthcare Inc.
Symbol: CHNG
Description: They are a leading independent healthcare technology platform that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.
Shares: 42.8 million
Price Range: $16.00-$19.00
Trade Date: Thursday, 6/27
Underwriter(s): Barclays, Goldman Sachs, JP Morgan
Terms Added: 6-14-19

Company: Linx S.A.
Symbol: LINX
Description: They are a leading cloud-based technology company in Latin America and a market leader in Brazil in terms of revenue.
Shares: 29.3 million
Price Range: $8.68-$8.68
Trade Date: Wednesday, 6/26
Underwriter(s): Goldman Sachs, JP Morgan, Jefferies, BofA Merrill Lynch, Itau BBA
Terms Added: 6-13-19
Common Shares Listed on Novo Mercado segment of the B3 S.A

Company: Cambium Networks, Inc
Symbol: CMBM
Description: They provide wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises and government agencies.
Shares: 5.8 million
Price Range: $13.00-$15.00
Trade Date: Wednesday, 6/26
Underwriter(s): JP Morgan, Goldman Sachs
Co-Manager(s): Deutsche Bank, Raymond James, JMP Securities, Oppenheimer
Terms Added: 6-13-19

Company: Dermavant Sciences, Inc.
Symbol: DRMT
Description: They are a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in medical dermatology.
Shares: 7.7 million
Price Range: $12.00-$14.00
Market Cap: $295m-$345m
Trade Date: Thursday, 6/20
Underwriter(s): Jefferies, SVB Leerink, Guggenheim Securities
Terms Added: 6-10-19

Company: Grocery Outlet Holding Corp.
Symbol: GO
Description: They are a high-growth, extreme value retailer of quality, name-brand consumables and fresh products sold through a network of independently operated stores.
Shares: 17.2 million
Price Range: $15.00-$17.00
Trade Date: Thursday, 6/20
Underwriter(s): BofA Merrill Lynch, Morgan Stanley, Deutsche Bank, Jefferies, Barclays, Goldman Sachs, Guggenheim Securities, UBS Investment Bank, Cowen
Co-Manager(s): Telsey Advisory Group, Drexel Hamilton, Penserra Securities LLC
Terms Added: 6-10-19

Company: Prevail Therapeutics Inc.
Symbol: PRVL
Description: They are a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with devastating neurodegenerative diseases.
Shares: 7.35 million
Price Range: $16.00-$18.00
Market Cap: $545m-$612m
Trade Date: Thursday, 6/20
Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Cowen
Co-Manager(s): Wedbush PacGrow
Terms Added: 6-10-19

Company: Atreca Inc
Symbol: BCEL
Description: They are a biopharmaceutical company utilizing our differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types.
Shares: 7.35 million
Price Range: $16.00-$18.00
Market Cap: $430m-$480m
Trade Date: Thursday, 6/20
Underwriter(s): Cowen, Evercore ISI, Stifel
Co-Manager(s): Canaccord Genuity, Brookline Capital
Terms Added: 6-10-19

Company: Akero Therapeutics
Symbol: AKRO
Description: They are a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical need.
Shares: 5 million
Price Range: $14.00-$16.00
Market Cap: $370m-$420m
Trade Date: Thursday, 6/20
Underwriter(s): JP Morgan, Jefferies, Evercore ISI
Co-Manager(s): Roth Capital
Terms Added: 6-10-19